Raiffeisen Bank International’s Beam Therapeutics BEAM Stock Holding History

Raiffeisen Bank International’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.57M	Hold	45,000	–	–	0.02%	350
2026 Q1	$986K	Buy	45,000 +2,000	+5%	+$55.5K	0.01%	388
2025 Q4	$1.2M	Hold	43,000	–	–	0.02%	323
2025 Q3	$1.03M	Buy	43,000 +8,000	+23%	+$159K	0.01%	333
2025 Q2	$587K	Hold	35,000	–	–	0.01%	360
2025 Q1	$777K	Sell	35,000 -15,000	-30%	-$393K	0.01%	306
2024 Q4	$1.26M	Buy	+50,000	New	+$1.28M	0.02%	252

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Raiffeisen Bank International's BEAM Position: Q2 2026 in Review

Raiffeisen Bank International held its Beam Therapeutics (BEAM) position steady in Q2 2026 at 45,000 shares worth $1.57M. The position accounts for 0.02% of the portfolio, ranked #350.

Raiffeisen Bank International first reported a position in BEAM in Q4 2024 and has held it in 7 quarters since. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

Raiffeisen Bank International held 45,000 shares of Beam Therapeutics worth $1.57M as of Q2 2026.
Raiffeisen Bank International left its Beam Therapeutics share count unchanged in Q2 2026.
Beam Therapeutics made up 0.02% of Raiffeisen Bank International's portfolio in Q2 2026, its #350 holding.
Raiffeisen Bank International first reported a position in Beam Therapeutics in Q4 2024 and has held it in 7 quarters since.
277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on Raiffeisen Bank International's 13F filing for Q2 2026, filed 3 Aug 2026.